Panion & BF Biotech Inc
TWSE:1760

Watchlist Manager
Panion & BF Biotech Inc Logo
Panion & BF Biotech Inc
TWSE:1760
Watchlist
Price: 65.9 TWD -0.9% Market Closed
Market Cap: 5.7B TWD

Panion & BF Biotech Inc
Operating Expenses

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Panion & BF Biotech Inc
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Panion & BF Biotech Inc
TWSE:1760
Operating Expenses
-NT$864.7m
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
-5%
Y
YungShin Global Holding Corp
TWSE:3705
Operating Expenses
-NT$2.3B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
-2%
ScinoPharm Taiwan Ltd
TWSE:1789
Operating Expenses
-NT$974.5m
CAGR 3-Years
-4%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Operating Expenses
-NT$5.4B
CAGR 3-Years
-15%
CAGR 5-Years
-12%
CAGR 10-Years
-7%
Standard Chem & Pharm Co Ltd
TWSE:1720
Operating Expenses
-NT$1.6B
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
-4%
C
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
Operating Expenses
-NT$748m
CAGR 3-Years
-46%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
No Stocks Found

Panion & BF Biotech Inc
Glance View

Market Cap
5.7B TWD
Industry
Pharmaceuticals

Panion & BF Biotech, Inc. engages in the manufacturing and sales of medicines, cosmetics, and formula foods. The company is headquartered in Taipei City, Taipei. The company went IPO on 2004-06-14. The firm is also involved in the manufacture and sales of various kinds of cosmetics. The firm's products also include formula food, medical devices, animal drugs, pet drugs, feed and environmental health drugs. The firm also provides biotechnology services. The firm distributes its products in Taiwan market and to the mainland China, Hong Kong and Macau markets.

Panion & BF Biotech Inc Intrinsic Value
HIDDEN
Show

See Also

What is Panion & BF Biotech Inc's Operating Expenses?
Operating Expenses
-864.7m TWD

Based on the financial report for Dec 31, 2024, Panion & BF Biotech Inc's Operating Expenses amounts to -864.7m TWD.

What is Panion & BF Biotech Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-5%

Over the last year, the Operating Expenses growth was -6%. The average annual Operating Expenses growth rates for Panion & BF Biotech Inc have been -5% over the past three years , -6% over the past five years , and -5% over the past ten years .

Back to Top